Fulgent Genetics and Helio Health partners to commercialize early cancer detection tests
Partnership enables broad reach of cfDNA methylation blood tests for early cancer detection
Partnership enables broad reach of cfDNA methylation blood tests for early cancer detection
First installation of AI-powered AMULET SOPHINITY at NM Medical aims to strengthen early breast cancer detection
We are building the bridge between complex molecular data and everyday clinical decisions
Health of the Nation 2026, based on over 3 million assessments, finds rising diabetes, obesity, and hidden cardiac risks in under-30s and working professionals
MoU to deploy Qure.ai’s chest X-ray solution across 20 government facilities aims to improve early detection in urban and rural populations
Leading the showcase is FCT iStream, Fujifilm’s latest CT scanner built on a “Less is More” design philosophy
Pangea will use its integrated validation platform and regulatory expertise to oversee analytical and clinical validation of Gene Solutions’ multi-omics technologies.
Using a combination of blood and faecal samples, the service examines key biomarkers, including hereditary genetic status
Freenome expects the combined company to receive approximately $330 million in proceeds at closing
Abbott is eyeing to become a global powerhouse in early cancer detection and precision oncology
Subscribe To Our Newsletter & Stay Updated